Review Article, J Liver Dis Transplant Vol: 4 Issue: 1
Nonalcoholic Fatty Liver Disease (NAFLD) after Liver Transplantation: A Mini-Review
| Claudia P Oliveira1*, Mário R Alvares-da-Silva2 and Luiz A Carneiro D’Albuquerque1 | |
| 1Department of Gastroenterology (LIM-07/ LIM-37), University of São Paulo School of Medicine, São Paulo, Brazil | |
| 2Division of Gastroenterology, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil | |
| Corresponding author : Claudia Pinto Marques Souza de Oliveira Department of Gastroenterology, School Medicine, University of São Paulo, Brazil Tel: +55- 11-30617301 Fax: +55-11-26617830; E-mail: cpm@usp.br |
|
| Received: January 09, 2015 Accepted: Februvary 10, 2015 Published: Februvary 16, 2015 | |
| Citation: Oliveira C, Alvares-da-Silva MR, D’Albuquerque LAC (2015) Endovascular Treatment of Symptomatic Intrahepatic Portosystemic Venous Shunt Using Amplatzer Vascular Plug II. J Liver: Dis Transplant 4:1. doi:10.4172/2325-9612.1000127 |
Abstract
Nonalcoholic Fatty Liver Disease (NAFLD) after Liver Transplantation: A Mini-Review
Nonalcoholic fatty liver disease (NAFLD) encompasses a large spectrum of disease including simple steatosis, nonalcoholic steatohepatitis (NASH) and in some patients liver fibrosis, cirrhosis, liver failure and hepatocellular carcinoma. In the last few years NAFLD has became the most common liver disease in Western countries and has been recognized an important indication for the liver transplantation as well. Advances in medical therapy and surgical techniques have transformed the long-term survival of liver-transplant (LT) recipients. Currently metabolic syndrome and NAFLD recurrence or de novo NAFLD are common among LT NAFLD recipients since they present an increased risk of metabolic disturbances as a natural result of their personal characteristics.
